SOLESENCE, INC. SLSN
Nasdaq · XNAS · stock · Perfumes, Cosmetics & Other Toilet Preparations
Chart by TradingView
3/9
Piotroski F — financial health
-3.7
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $62.1M | $1.8M | $16.1M | — | $17.6M |
| 2024 | $52.3M | $4.2M | $16.2M | -$2.6M | $14.9M |
| 2023 | $37.3M | -$4.4M | $7.8M | -$3.1M | $1.9M |
| 2022 | $37.3M | -$2.6M | $8.4M | -$4.5M | $5.6M |
| 2021 | $29.5M | $2.3M | $8.7M | $447,000 | $7.5M |
| 2020 | $17.1M | $989,000 | $6.0M | -$2.9M | $2.7M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| WHITMORE R JANET | director | 2025-12-24 | Buy | 1,500 | $1.91 |
| WHITMORE R JANET | director | 2025-12-24 | Buy | 1,000 | $1.92 |
| WHITMORE R JANET | director | 2025-11-19 | Buy | 5,000 | $1.95 |
| WHITMORE R JANET | director | 2025-11-19 | Buy | 5,000 | $1.89 |
| WHITMORE R JANET | director | 2025-11-18 | Buy | 267 | $1.83 |
| WHITMORE R JANET | director | 2025-11-17 | Buy | 5,000 | $1.87 |
| WHITMORE R JANET | director | 2025-11-14 | Buy | 19,789 | $1.73 |
| Cureton Kevin | Chief Operating Officer | 2025-06-06 | Option exercise | 38,807 | $0.42 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -3.7 (distress)
- Working capital / assets 0.297
- Retained earnings / assets -1.971
- EBIT / assets 0.031
- Equity / liabilities 0.544
Source: SEC EDGAR filings · CIK 0000883107 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.